Phase I Study of Palbociclib in Combination With Cisplatin or Carboplatin in Advanced Solid Malignancies
Summary
The purpose of this phase I trial is to study the side effects and best dose of palbociclib with cisplatin or carboplatin in treating patients with solid tumors that have spread to other places and usually cannot be cured or controlled with treatment.
General Information
NCT#: NCT02897375
Study ID: Winship3263-16
Trial Phase: Phase I
Trial Sponsor: Pfizer, Emory University
Therapies Used in This Trial: Cisplatin, Carboplatin, Palbociclib